Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Understanding factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review using the Theoretical Domains Framework (2023)
Journal Article
Alharbi, A. B., Berrou, I., Umaru, N., Al Hamid, A., & Shebl, N. A. (2024). Understanding factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review using the Theoretical Domains Framework. Research in Social and Administrative Pharmacy, 20(2), 86-98. https://doi.org/10.1016/j.sapharm.2023.10.004

Background: Adverse drug reactions (ADRs) are known to cause hospitalisation, longer hospital stays, as well as higher healthcare costs and mortality. Unrecognised ADRs are anticipated throughout the medicine lifecycle as, before the medicine reaches... Read More about Understanding factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review using the Theoretical Domains Framework.

463 Understanding the role of nurses in deprescribing medicines for older people: A systematic review (2023)
Journal Article
Hart, L., & Berrou, I. (2023). 463 Understanding the role of nurses in deprescribing medicines for older people: A systematic review. International Journal of Pharmacy Practice, 31(Supplement 1), i18-i19. https://doi.org/10.1093/ijpp/riad021.020

Introduction: It is predicted that by 2035, two-thirds of people aged over 65 in the UK will be living with multiple health conditions requiring a life-long intake of multiple medicines (1). Recent reports suggest that over 8.4 million people take 5... Read More about 463 Understanding the role of nurses in deprescribing medicines for older people: A systematic review.

Making the case for pharmacogenomics in the management of mental health conditions (2023)
Journal Article
Berrou, I., Ramsunder, A., & Palmer, R. (2023). Making the case for pharmacogenomics in the management of mental health conditions. Pharmaceutical Journal, 310, 7969. https://doi.org/10.1211/PJ.2023.1.171747

Mental health conditions are the largest single cause of disability in the UK and among the top ten causes of disability worldwide. The prevalence of mental health conditions is increasing rapidly, especially since the COVID-19 pandemic. Overall, the... Read More about Making the case for pharmacogenomics in the management of mental health conditions.